First and Second Line Highly Active Anti-Retroviral Therapy Failure in HIV Infected Nigerian Children at University of Abuja Teaching Hospital Gwagwalada, Nigeria

Journal Title: Journal of HIV for Clinical and Scientific Research - Year 2015, Vol 2, Issue 2

Abstract

Background: In high-income countries, viral load is routinely used for monitoring HIV patients on antiretroviral therapy for early detection of drug failure. This is not the case in most resource limited settings like ours where only WHO immunological and clinical criteria are used for monitoring. This study is aimed at determining the rate/time of failure to 1st and 2nd antiretroviral drugs in children in our centers. Method: Is a retrospective study of children ≤18 years switched to 2nd line antiretroviral regimen and those requiring third line drugs from Jan 2006 to June 2015 in our health institution. Data analysis was conducted using SPSS version 16.0 software and statistical significance set at p < 0.05. Result: Sixteen percent (82/514) of children on 1st line medication were switched to 2nd line drugs with switch over rate of 9 persons/year, and 6/82 (7.3%) required 3rd line medication. The median switch over time was 31.3 months (IQR 26.4-36.2) for 2nd line medication, and 42.6 months (IQR 40.1-44.3) from time of switch to 2nd line drugs for those requiring 3rd line regimen. Over 90% of patients switched to 2nd line drugs were between 9-18 years, none was an infant. The mean CD4 cell count and viral load before switch to 2nd line drugs were 109.09±29.23 cell/mm3 and 180,480.29±35,303 copies/ml, and 89.42±28.67 cell/mm3/ 237,337.5±64,619 copies/ml for those requiring 3rd line medications. There was over 450 fold increase in viral load from the expected undetectable level of 400 copies/ml after 6 months on medication before patients were switch to 2nd line drugs, and over 590 folds increase for those that require 3rd line medications. Significant difference was seen in the mean CD4 cell count and weight of those with adherence of ≥ 95% and ≤ 95% (p values were <0.05). Conclusion: WHO immunological and clinical criteria were found not to be ideal for monitoring of children on antiretroviral therapy. Six monthly viral load monitoring and resistance testing should be introduced in Nigerian guideline for managing HIV children for better therapeutic and pharmaco-economic outcomes. Third line medication should also be made available in the country and intensification of adherence is required in adolescent age group.

Authors and Affiliations

Okechukwu Adaora A, Amajuoyi Frank I

Keywords

Related Articles

HIV/AIDS Risk for Young Female Petty Traders at Car Parks

Though the HVI/AIDS prevalence rate in The Gambia is one of the lowest in the sub-region, the disease and its associated effects has always been a concern both to the government, non-governmental organizations, professio...

Commentary: Role of MicroRNAs in HIV Related Studies

Micro RNAs (miRNAs) are well known regulatory factor of physiological and developmental processes, it has been revealed that many miRNAs contribute the initiation and progression of various cancers. Micro RNAs are being...

Burden of HIV Infection in Children with Severe Acute Malnutrition at the University of Abuja Teaching Hospital Gwagwalada, Nigeria

Background: Human Immunodeficiency Virus pandemic has adversely affected the nutritional status of many children in the sub region, an area where malnutrition is also endemic. The study was aimed at assessing the burden...

Development of Mucoadhesive Gel Microbicide to Target Mucosal HIV Reservoirs

The wide use of microbicide is mainly depends on its effectiveness, less frequent application, ready availability and most importantly cost. The aim of this work was to develop affordable microbicide mucoadhesive gel for...

Pseudomembranous Candidiasis Indicates High Level Drug Resistance among Patients on Antiretroviral Treatment in Nairobi East District, Kenya

Objectives: The aim of this study was to determine antiretroviral drug resistance patterns in patients on long-term antiretroviral therapy presenting with OPC. Methods: An exploratory survey was performed among HIV-infec...

Download PDF file
  • EP ID EP348004
  • DOI 10.17352/2455-3786.000014
  • Views 94
  • Downloads 0

How To Cite

Okechukwu Adaora A, Amajuoyi Frank I (2015). First and Second Line Highly Active Anti-Retroviral Therapy Failure in HIV Infected Nigerian Children at University of Abuja Teaching Hospital Gwagwalada, Nigeria. Journal of HIV for Clinical and Scientific Research, 2(2), 49-54. https://europub.co.uk./articles/-A-348004